Efficacy and Safety of Chemotherapy Following Anti-PD-1 Antibody Therapy for Gastric Cancer: A Case of Sclerosing Cholangitis

Immunotherapy targeting programmed cell death-1 (PD-1) signaling is becoming the standard of care for advanced gastric cancer. We herein report a patient with gastric adenocarcinoma with peritoneal dissemination who was treated with nab-paclitaxel and ramucirumab following nivolumab and developed sc...

Descripción completa

Detalles Bibliográficos
Autores principales: Kono, Masashi, Sakurai, Toshiharu, Okamoto, Kazuki, Masaki, Shou, Nagai, Tomoyuki, Komeda, Yoriaki, Kamata, Ken, Minaga, Kosuke, Yamao, Kentarou, Takenaka, Mamoru, Watanabe, Tomohiro, Nishida, Naoshi, Kudo, Masatoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543221/
https://www.ncbi.nlm.nih.gov/pubmed/30626829
http://dx.doi.org/10.2169/internalmedicine.1981-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543221/
https://www.ncbi.nlm.nih.gov/pubmed/30626829
http://dx.doi.org/10.2169/internalmedicine.1981-18

Ejemplares similares